{"nct_id":"NCT04557462","title":"A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2021-09-20","start_date_type":"ACTUAL","primary_completion_date":"2032-11-11","primary_completion_date_type":"ESTIMATED","completion_date":"2032-11-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}